CN104316630A - 苦碟子注射液糖类成分的含量测定方法 - Google Patents
苦碟子注射液糖类成分的含量测定方法 Download PDFInfo
- Publication number
- CN104316630A CN104316630A CN201410021654.2A CN201410021654A CN104316630A CN 104316630 A CN104316630 A CN 104316630A CN 201410021654 A CN201410021654 A CN 201410021654A CN 104316630 A CN104316630 A CN 104316630A
- Authority
- CN
- China
- Prior art keywords
- add
- injection
- water
- baths
- sample
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000007924 injection Substances 0.000 title claims abstract description 55
- 238000002347 injection Methods 0.000 title claims abstract description 55
- 238000000034 method Methods 0.000 title claims abstract description 46
- 150000001720 carbohydrates Chemical class 0.000 title claims abstract description 28
- 241001412304 Ixeris Species 0.000 title abstract description 14
- 150000001323 aldoses Chemical class 0.000 claims abstract description 17
- 238000001212 derivatisation Methods 0.000 claims abstract description 15
- 208000007976 Ketosis Diseases 0.000 claims abstract description 9
- 150000002584 ketoses Chemical class 0.000 claims abstract description 9
- 238000002360 preparation method Methods 0.000 claims abstract description 8
- 238000004817 gas chromatography Methods 0.000 claims abstract description 4
- 241001301715 Crepidiastrum sonchifolium Species 0.000 claims description 42
- 238000006243 chemical reaction Methods 0.000 claims description 20
- 239000000470 constituent Substances 0.000 claims description 16
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 15
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 claims description 14
- IJOOHPMOJXWVHK-UHFFFAOYSA-N chlorotrimethylsilane Chemical compound C[Si](C)(C)Cl IJOOHPMOJXWVHK-UHFFFAOYSA-N 0.000 claims description 14
- 238000004108 freeze drying Methods 0.000 claims description 13
- 238000004458 analytical method Methods 0.000 claims description 9
- 238000001816 cooling Methods 0.000 claims description 9
- 238000012360 testing method Methods 0.000 claims description 9
- -1 oxammonium hydrochlorides Chemical class 0.000 claims description 8
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 7
- WTDHULULXKLSOZ-UHFFFAOYSA-N Hydroxylamine hydrochloride Chemical compound Cl.ON WTDHULULXKLSOZ-UHFFFAOYSA-N 0.000 claims description 7
- 241001597008 Nomeidae Species 0.000 claims description 7
- 239000008103 glucose Substances 0.000 claims description 7
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 claims description 7
- 239000005051 trimethylchlorosilane Substances 0.000 claims description 7
- 229930091371 Fructose Natural products 0.000 claims description 6
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 claims description 6
- 239000005715 Fructose Substances 0.000 claims description 6
- 150000004075 acetic anhydrides Chemical class 0.000 claims description 6
- 238000002156 mixing Methods 0.000 claims description 6
- 150000003222 pyridines Chemical class 0.000 claims description 6
- 239000006228 supernatant Substances 0.000 claims description 6
- WQZGKKKJIJFFOK-IVMDWMLBSA-N D-allopyranose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@H](O)[C@@H]1O WQZGKKKJIJFFOK-IVMDWMLBSA-N 0.000 claims description 4
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 claims description 4
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 claims description 4
- 229960000367 inositol Drugs 0.000 claims description 4
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 claims description 4
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 claims description 3
- 238000010521 absorption reaction Methods 0.000 claims description 3
- WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 claims description 3
- PYMYPHUHKUWMLA-WDCZJNDASA-N arabinose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)C=O PYMYPHUHKUWMLA-WDCZJNDASA-N 0.000 claims description 3
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 claims description 3
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 claims description 3
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 claims description 3
- 239000012159 carrier gas Substances 0.000 claims description 3
- 230000006837 decompression Effects 0.000 claims description 3
- 229930182830 galactose Natural products 0.000 claims description 3
- 239000007789 gas Substances 0.000 claims description 3
- 230000007935 neutral effect Effects 0.000 claims description 3
- 238000005086 pumping Methods 0.000 claims description 3
- 239000002904 solvent Substances 0.000 claims description 3
- 239000006200 vaporizer Substances 0.000 claims description 3
- 239000001307 helium Substances 0.000 claims description 2
- 229910052734 helium Inorganic materials 0.000 claims description 2
- SWQJXJOGLNCZEY-UHFFFAOYSA-N helium atom Chemical compound [He] SWQJXJOGLNCZEY-UHFFFAOYSA-N 0.000 claims description 2
- 238000002290 gas chromatography-mass spectrometry Methods 0.000 abstract description 17
- 239000000126 substance Substances 0.000 abstract description 5
- 238000002203 pretreatment Methods 0.000 abstract description 3
- 238000001228 spectrum Methods 0.000 abstract 1
- 239000000203 mixture Substances 0.000 description 12
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 10
- 239000013558 reference substance Substances 0.000 description 9
- 239000003814 drug Substances 0.000 description 8
- 238000011160 research Methods 0.000 description 7
- 239000003153 chemical reaction reagent Substances 0.000 description 6
- 239000000047 product Substances 0.000 description 6
- 238000003556 assay Methods 0.000 description 5
- 229940079593 drug Drugs 0.000 description 5
- 238000001514 detection method Methods 0.000 description 4
- 238000005516 engineering process Methods 0.000 description 4
- 238000011084 recovery Methods 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 description 3
- LPQOADBMXVRBNX-UHFFFAOYSA-N ac1ldcw0 Chemical compound Cl.C1CN(C)CCN1C1=C(F)C=C2C(=O)C(C(O)=O)=CN3CCSC1=C32 LPQOADBMXVRBNX-UHFFFAOYSA-N 0.000 description 3
- 239000000706 filtrate Substances 0.000 description 3
- 229930182486 flavonoid glycoside Natural products 0.000 description 3
- 150000007955 flavonoid glycosides Chemical class 0.000 description 3
- 229930182470 glycoside Natural products 0.000 description 3
- 150000002338 glycosides Chemical class 0.000 description 3
- 230000014759 maintenance of location Effects 0.000 description 3
- 239000003182 parenteral nutrition solution Substances 0.000 description 3
- 229920001282 polysaccharide Polymers 0.000 description 3
- 239000005017 polysaccharide Substances 0.000 description 3
- WQZGKKKJIJFFOK-SVZMEOIVSA-N (+)-Galactose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-SVZMEOIVSA-N 0.000 description 2
- 206010002383 Angina Pectoris Diseases 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- OIRDTQYFTABQOQ-KQYNXXCUSA-N adenosine Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O OIRDTQYFTABQOQ-KQYNXXCUSA-N 0.000 description 2
- 230000000840 anti-viral effect Effects 0.000 description 2
- 206010008118 cerebral infarction Diseases 0.000 description 2
- 208000026106 cerebrovascular disease Diseases 0.000 description 2
- 210000000038 chest Anatomy 0.000 description 2
- 208000029078 coronary artery disease Diseases 0.000 description 2
- 238000010828 elution Methods 0.000 description 2
- 229930003935 flavonoid Natural products 0.000 description 2
- 150000002215 flavonoids Chemical class 0.000 description 2
- 235000017173 flavonoids Nutrition 0.000 description 2
- 150000004676 glycans Chemical class 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 238000001819 mass spectrum Methods 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 150000002772 monosaccharides Chemical class 0.000 description 2
- 238000010183 spectrum analysis Methods 0.000 description 2
- 238000011282 treatment Methods 0.000 description 2
- JMGZEFIQIZZSBH-UHFFFAOYSA-N Bioquercetin Natural products CC1OC(OCC(O)C2OC(OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5)C(O)C2O)C(O)C(O)C1O JMGZEFIQIZZSBH-UHFFFAOYSA-N 0.000 description 1
- 239000002126 C01EB10 - Adenosine Substances 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- RFSUNEUAIZKAJO-VRPWFDPXSA-N D-Fructose Natural products OC[C@H]1OC(O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-VRPWFDPXSA-N 0.000 description 1
- 206010014080 Ecchymosis Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 201000001429 Intracranial Thrombosis Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 208000002193 Pain Diseases 0.000 description 1
- 229930182558 Sterol Natural products 0.000 description 1
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 1
- 229960005305 adenosine Drugs 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- GZCGUPFRVQAUEE-KVTDHHQDSA-N aldehydo-D-mannose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)C=O GZCGUPFRVQAUEE-KVTDHHQDSA-N 0.000 description 1
- 229940089206 anhydrous dextrose Drugs 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- ZYGHJZDHTFUPRJ-UHFFFAOYSA-N benzo-alpha-pyrone Natural products C1=CC=C2OC(=O)C=CC2=C1 ZYGHJZDHTFUPRJ-UHFFFAOYSA-N 0.000 description 1
- 238000004166 bioassay Methods 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- BRPQOXSCLDDYGP-UHFFFAOYSA-N calcium oxide Chemical compound [O-2].[Ca+2] BRPQOXSCLDDYGP-UHFFFAOYSA-N 0.000 description 1
- 239000000292 calcium oxide Substances 0.000 description 1
- ODINCKMPIJJUCX-UHFFFAOYSA-N calcium oxide Inorganic materials [Ca]=O ODINCKMPIJJUCX-UHFFFAOYSA-N 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 235000001671 coumarin Nutrition 0.000 description 1
- 150000004775 coumarins Chemical class 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 238000012850 discrimination method Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- IVTMALDHFAHOGL-UHFFFAOYSA-N eriodictyol 7-O-rutinoside Natural products OC1C(O)C(O)C(C)OC1OCC1C(O)C(O)C(O)C(OC=2C=C3C(C(C(O)=C(O3)C=3C=C(O)C(O)=CC=3)=O)=C(O)C=2)O1 IVTMALDHFAHOGL-UHFFFAOYSA-N 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 229930003944 flavone Natural products 0.000 description 1
- 150000002212 flavone derivatives Chemical class 0.000 description 1
- 235000011949 flavones Nutrition 0.000 description 1
- BJHIKXHVCXFQLS-UYFOZJQFSA-N fructose group Chemical group OCC(=O)[C@@H](O)[C@H](O)[C@H](O)CO BJHIKXHVCXFQLS-UYFOZJQFSA-N 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 230000002218 hypoglycaemic effect Effects 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 238000002414 normal-phase solid-phase extraction Methods 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 239000010023 qingre quyu Substances 0.000 description 1
- 238000003908 quality control method Methods 0.000 description 1
- FDRQPMVGJOQVTL-UHFFFAOYSA-N quercetin rutinoside Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 FDRQPMVGJOQVTL-UHFFFAOYSA-N 0.000 description 1
- 238000004064 recycling Methods 0.000 description 1
- IKGXIBQEEMLURG-BKUODXTLSA-N rutin Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@@H]1OC[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-BKUODXTLSA-N 0.000 description 1
- ALABRVAAKCSLSC-UHFFFAOYSA-N rutin Natural products CC1OC(OCC2OC(O)C(O)C(O)C2O)C(O)C(O)C1OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5 ALABRVAAKCSLSC-UHFFFAOYSA-N 0.000 description 1
- 235000005493 rutin Nutrition 0.000 description 1
- 229960004555 rutoside Drugs 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 239000013049 sediment Substances 0.000 description 1
- 239000008354 sodium chloride injection Substances 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 150000003432 sterols Chemical class 0.000 description 1
- 235000003702 sterols Nutrition 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 150000003505 terpenes Chemical class 0.000 description 1
- 235000007586 terpenes Nutrition 0.000 description 1
- 229940126680 traditional chinese medicines Drugs 0.000 description 1
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 1
- 239000008215 water for injection Substances 0.000 description 1
Landscapes
- Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
Abstract
Description
Claims (1)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410021654.2A CN104316630B (zh) | 2014-01-17 | 2014-01-17 | 苦碟子注射液糖类成分的含量测定方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410021654.2A CN104316630B (zh) | 2014-01-17 | 2014-01-17 | 苦碟子注射液糖类成分的含量测定方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN104316630A true CN104316630A (zh) | 2015-01-28 |
CN104316630B CN104316630B (zh) | 2016-03-02 |
Family
ID=52371890
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410021654.2A Active CN104316630B (zh) | 2014-01-17 | 2014-01-17 | 苦碟子注射液糖类成分的含量测定方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104316630B (zh) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106841434A (zh) * | 2017-01-17 | 2017-06-13 | 华楠 | 苦碟子注射液指纹图谱检查方法 |
CN107655988A (zh) * | 2017-09-11 | 2018-02-02 | 夏永刚 | 一种利用气相色谱‑质谱分析方法同时检测酮糖和氨基糖的方法 |
CN110632223A (zh) * | 2019-07-16 | 2019-12-31 | 夏永刚 | 一种中药多糖结构特征指纹图谱及其构建方法和应用 |
-
2014
- 2014-01-17 CN CN201410021654.2A patent/CN104316630B/zh active Active
Non-Patent Citations (6)
Title |
---|
任清等: "衍生化-毛细管气相色谱法同时测定糖尿病大鼠坐骨神经中葡萄糖、山梨醇、肌醇", 《分析实验室》 * |
孙国祥等: "注射用苦碟子HPLC数字化指纹图谱研究", 《中成药》 * |
张娜等: "液相色谱法测定苦碟子注射液中腺嘌呤核苷的含量", 《中成药》 * |
王静等: "色谱法在糖类化合物分析中的应用", 《分析化学(FENXI HUAXUE)评述与进展》 * |
陈英红等: "苦碟子药材HPLC指纹图谱研究", 《中成药》 * |
齐晓丽等: "苦碟子挥发油化学成分的分析", 《分子科学学报》 * |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106841434A (zh) * | 2017-01-17 | 2017-06-13 | 华楠 | 苦碟子注射液指纹图谱检查方法 |
CN107655988A (zh) * | 2017-09-11 | 2018-02-02 | 夏永刚 | 一种利用气相色谱‑质谱分析方法同时检测酮糖和氨基糖的方法 |
CN110632223A (zh) * | 2019-07-16 | 2019-12-31 | 夏永刚 | 一种中药多糖结构特征指纹图谱及其构建方法和应用 |
Also Published As
Publication number | Publication date |
---|---|
CN104316630B (zh) | 2016-03-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN111443142B (zh) | 一种保元汤制剂中多指标成分的同时检测方法 | |
CN102617745B (zh) | 灵芝多糖f31的制备方法及其降血糖功能 | |
CN110907580B (zh) | 一种保元汤的hplc特征图谱的检测方法 | |
CN107607649B (zh) | 一种黑骨藤的检测方法 | |
CN105467059A (zh) | 一种治疗血尿的中药组合物的质量检测方法 | |
CN105259268A (zh) | 一种银杏酮酯中黄酮类和有机酸类成分指纹图谱的检测方法及其应用 | |
CN104316630B (zh) | 苦碟子注射液糖类成分的含量测定方法 | |
CN104069348A (zh) | 黄精提取物及其制备方法与应用 | |
CN111487343A (zh) | 一种保元汤制剂指纹图谱的建立方法 | |
CN107238671B (zh) | 一种贞芪扶正制剂中多种成分的含量测定方法 | |
CN103239467B (zh) | 姬松茸多糖及其制备方法 | |
CN103592391B (zh) | 贞芪扶正制剂中特女贞苷的含量测定方法 | |
CN109613138A (zh) | 一种利用pmp-hplc-内标标准曲线法同时测定太子参中葡萄糖和半乳糖含量的方法 | |
CN108226325A (zh) | 葶苈生脉口服液组合物指纹图谱的建立方法 | |
CN101745024A (zh) | 一种参麦注射液的质量控制方法 | |
CN103115985B (zh) | Hplc-dad法同时测定苦碟子注射液中六种黄酮类成分的方法 | |
CN103163243A (zh) | Hplc-dad法同时测定苦碟子注射液中五种有机酸类成分含量的方法 | |
CN112730671B (zh) | 一种丝瓜络标准汤剂的超高效液相色谱检测方法及其应用 | |
CN102628838B (zh) | 一种药材马蓝的hplc指纹图谱构建方法 | |
CN109771463A (zh) | 新疆一枝蒿提取物及其制备方法和用途 | |
CN101486772B (zh) | 一种槲寄生多糖及其制备方法和用途 | |
CN111956734A (zh) | 一种咽康含片的优化提取方法 | |
CN109828040B (zh) | 墨旱莲药材uplc特征图谱的构建方法和检测方法 | |
CN112557553A (zh) | 一种当归六黄汤组合物的指纹图谱构建方法和检测方法 | |
CN111588739A (zh) | 桑黄提取物的制备方法及应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Determination of saccharides in Kudiezi Injection Effective date of registration: 20210610 Granted publication date: 20160302 Pledgee: Tonghua Branch of China Everbright Bank Co.,Ltd. Pledgor: TONGHUA HUAXIA PHARMACEUTICAL Co.,Ltd. Registration number: Y2021220000060 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20220823 Granted publication date: 20160302 Pledgee: Tonghua Branch of China Everbright Bank Co.,Ltd. Pledgor: TONGHUA HUAXIA PHARMACEUTICAL Co.,Ltd. Registration number: Y2021220000060 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Content determination method of saccharides in Kudiezi injection Effective date of registration: 20220826 Granted publication date: 20160302 Pledgee: Tonghua Branch of China Everbright Bank Co.,Ltd. Pledgor: TONGHUA HUAXIA PHARMACEUTICAL Co.,Ltd. Registration number: Y2022220000059 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20230905 Granted publication date: 20160302 Pledgee: Tonghua Branch of China Everbright Bank Co.,Ltd. Pledgor: TONGHUA HUAXIA PHARMACEUTICAL Co.,Ltd. Registration number: Y2022220000059 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Method for determination of carbohydrate components in Kudiezi injection Effective date of registration: 20230926 Granted publication date: 20160302 Pledgee: Tonghua Branch of China Everbright Bank Co.,Ltd. Pledgor: TONGHUA HUAXIA PHARMACEUTICAL Co.,Ltd. Registration number: Y2023220000098 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Granted publication date: 20160302 Pledgee: Tonghua Branch of China Everbright Bank Co.,Ltd. Pledgor: TONGHUA HUAXIA PHARMACEUTICAL Co.,Ltd. Registration number: Y2023220000098 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Method for determining the content of carbohydrate components in Kudiezi injection Granted publication date: 20160302 Pledgee: Tonghua Branch of China Everbright Bank Co.,Ltd. Pledgor: TONGHUA HUAXIA PHARMACEUTICAL Co.,Ltd. Registration number: Y2024220000076 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Granted publication date: 20160302 Pledgee: Tonghua Branch of China Everbright Bank Co.,Ltd. Pledgor: TONGHUA HUAXIA PHARMACEUTICAL Co.,Ltd. Registration number: Y2024220000076 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Method for determining the content of carbohydrate components in Kudiezi injection Granted publication date: 20160302 Pledgee: Tonghua Branch of China Everbright Bank Co.,Ltd. Pledgor: TONGHUA HUAXIA PHARMACEUTICAL Co.,Ltd. Registration number: Y2024220000083 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right |